Bioage Labs Stock Volatility

BIOA Stock

16.48 2.45 17.46%

BioAge Labs is slightly risky given 3 months investment horizon. BioAge Labs secures Sharpe Ratio (or Efficiency) of 0.26, which signifies that the company had a 0.26 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.7% are justified by taking the suggested risk. Use BioAge Labs Risk Adjusted Performance of 0.1954, downside deviation of 3.63, and Mean Deviation of 4.03 to evaluate company specific risk that cannot be diversified away.

Sharpe Ratio = 0.2646

High Returns	Best Equity
Good Returns
Average Returns			BIOA
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Based on monthly moving average BioAge Labs is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioAge Labs by adding it to a well-diversified portfolio.

Key indicators related to BioAge Labs' volatility include:

30 Days Market Risk

Slightly risky

Chance Of Distress

Low

30 Days Economic Sensitivity

Actively responds to the market

BioAge Labs Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of BioAge daily returns, and it is calculated using variance and standard deviation. We also use BioAge's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of BioAge Labs volatility.

Build AI portfolio with BioAge Stock

ESG Sustainability

While most ESG disclosures are voluntary, BioAge Labs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BioAge Labs' managers and investors.

Environmental

Governance

Social

Since volatility provides investors with entry points to take advantage of stock prices, companies, such as BioAge Labs can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of BioAge Labs at lower prices to lower their average cost per share. Similarly, when the prices of BioAge Labs' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities. Main indicators related to BioAge Labs' market risk premium analysis include:

Beta

1.68

Alpha

1.43

Risk

6.44

Sharpe Ratio

0.26

Expected Return

1.7

Moving together with BioAge Stock

0.81	AZN	AstraZeneca PLC ADR	Pair Corr
0.82	JNJ	Johnson Johnson	Pair Corr
0.88	MRK	Merck Company Aggressive Push	Pair Corr
0.72	NVS	Novartis AG ADR	Pair Corr
0.79	WMT	Walmart Common Stock	Pair Corr
0.88	SAR	Saratoga Investment Corp	Pair Corr
0.89	ACN	Accenture plc	Pair Corr
0.89	VLKAF	Volkswagen AG	Pair Corr
0.87	VWAGY	Volkswagen AG 110	Pair Corr
0.85	VLKPF	Volkswagen AG VZO	Pair Corr
0.84	WSFS	WSFS Financial	Pair Corr
0.78	F	Ford Motor Aggressive Push	Pair Corr
0.75	BOF	BranchOut Food Common	Pair Corr
0.94	ATI	Allegheny Technologies	Pair Corr
0.83	ACR-PC	ACRES Commercial Realty	Pair Corr
0.82	AXP	American Express	Pair Corr
0.67	TRV	The Travelers Companies	Pair Corr
0.63	MCD	McDonalds	Pair Corr
0.79	JPM	JPMorgan Chase Earnings Call Tomorrow	Pair Corr

Moving against BioAge Stock

0.83	HCM	HUTCHMED DRC	Pair Corr
0.76	JD	JD Inc Adr	Pair Corr
0.57	SNY	Sanofi ADR	Pair Corr

BioAge Labs Market Sensitivity And Downside Risk

BioAge Labs' beta coefficient measures the volatility of BioAge stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents BioAge stock's returns against your selected market. In other words, BioAge Labs's beta of 1.68 provides an investor with an approximation of how much risk BioAge Labs stock can potentially add to one of your existing portfolios. BioAge Labs is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioAge Labs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioAge Labs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Check current 90 days BioAge Labs correlation with market (Dow Jones Industrial)

1.43

1.68

Competition

3 Months Beta |Analyze BioAge Labs Demand Trend

Check current 90 days BioAge Labs correlation with market (Dow Jones Industrial)

BioAge Labs Volatility and Downside Risk

BioAge standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Using BioAge Put Option to Manage Risk

Put options written on BioAge Labs grant holders of the option the right to sell a specified amount of BioAge Labs at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of BioAge Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge BioAge Labs' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding BioAge Labs will be realized, the loss incurred will be offset by the profits made with the option trade.

BioAge Labs' PUT expiring on 2026-04-17

Profit

BioAge Labs Price At Expiration

Current BioAge Labs Insurance Chain

		Delta	Gamma	Open Int	Expiration	Current Spread	Last Price
Put	BIOA260417P00005000	-0.002541	1.09E-4	2	2026-04-17	0.0 - 4.9	0.0	View
Put	BIOA260417P00007500	-0.078239	0.00458	1	2026-04-17	0.0 - 4.9	0.0	View

View All BioAge Labs Options

BioAge Labs Stock Volatility Analysis

Volatility refers to the frequency at which BioAge Labs stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with BioAge Labs' price changes. Investors will then calculate the volatility of BioAge Labs' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of BioAge Labs' volatility:

Historical Volatility

This type of stock volatility measures BioAge Labs' fluctuations based on previous trends. It's commonly used to predict BioAge Labs' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for BioAge Labs' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on BioAge Labs' to be redeemed at a future date.

Transformation

The output start index for this execution was zero with a total number of output elements of sixty-one. BioAge Labs Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

BioAge Labs Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.6828 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioAge Labs will likely underperform.

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioAge Labs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioAge Labs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioAge stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

BioAge Labs has an alpha of 1.4267, implying that it can generate a 1.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predicted Return Density

Returns

BioAge Labs' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how bioage stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a BioAge Labs Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

BioAge Labs Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of BioAge Labs is 377.93. The daily returns are distributed with a variance of 41.48 and standard deviation of 6.44. The mean deviation of BioAge Labs is currently at 4.17. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.74

α	Alpha over Dow Jones	1.43	Details
β	Beta against Dow Jones	1.68	Details
σ	Overall volatility	6.44	Details
Ir	Information ratio	0.24	Details

BioAge Labs Stock Return Volatility

BioAge Labs historical daily return volatility represents how much of BioAge Labs stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 6.4407% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7018% volatility on return distribution over the 90 days horizon.

Performance

Timeline

Related Correlations Analysis

	LFCR	CGC	ALLO	EDIT	TKNO	ACB	AVIR	OMI	CABA	HUMA
LFCR		-0.05	0.5	-0.83	-0.76	-0.5	0.29	-0.78	-0.57	-0.87	LFCR
CGC	-0.05		0.31	0.32	0.29	0.79	-0.03	0.31	0.15	0.18	CGC
ALLO	0.5	0.31		-0.35	-0.33	0.04	0.11	-0.46	-0.33	-0.4	ALLO
EDIT	-0.83	0.32	-0.35		0.85	0.77	-0.33	0.87	0.59	0.91	EDIT
TKNO	-0.76	0.29	-0.33	0.85		0.67	-0.43	0.85	0.67	0.9	TKNO
ACB	-0.5	0.79	0.04	0.77	0.67		-0.29	0.69	0.46	0.65	ACB
AVIR	0.29	-0.03	0.11	-0.33	-0.43	-0.29		-0.19	-0.23	-0.32	AVIR
OMI	-0.78	0.31	-0.46	0.87	0.85	0.69	-0.19		0.62	0.89	OMI
CABA	-0.57	0.15	-0.33	0.59	0.67	0.46	-0.23	0.62		0.7	CABA
HUMA	-0.87	0.18	-0.4	0.91	0.9	0.65	-0.32	0.89	0.7		HUMA
	LFCR	CGC	ALLO	EDIT	TKNO	ACB	AVIR	OMI	CABA	HUMA

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HUMA	+ 0.91	EDIT
HUMA	+ 0.9	TKNO
HUMA	+ 0.89	OMI
OMI	+ 0.87	EDIT
TKNO	+ 0.85	EDIT
OMI	+ 0.85	TKNO

High negative correlations

HUMA	- 0.87	LFCR
EDIT	- 0.83	LFCR
OMI	- 0.78	LFCR
TKNO	- 0.76	LFCR
CABA	- 0.57	LFCR
ACB	- 0.5	LFCR

Risk-Adjusted Indicators

There is a big difference between BioAge Stock performing well and BioAge Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioAge Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LFCR	2.09	0.08	0.05	0.14	2.16	(2.51)	6.17	(4.01)	15.24
CGC	5.18	(0.04)	0.00	0.05	5.68	(6.65)	8.55	(10.81)	66.41
ALLO	3.81	0.25	0.08	0.17	4.37	(5.15)	9.76	(6.16)	27.43
EDIT	3.44	(1.02)	0.00	(0.46)	0.00	0.00	7.54	(8.82)	25.73
TKNO	2.89	(0.42)	0.00	(0.16)	0.00	0.00	6.29	(5.95)	21.07
ACB	2.68	(0.60)	0.00	(0.41)	0.00	0.00	3.56	(6.04)	26.49
AVIR	1.84	0.16	0.05	0.23	3.01	(1.91)	4.38	(3.27)	17.80
OMI	3.88	(0.91)	0.00	(1.79)	0.00	0.00	6.88	(13.10)	27.99
CABA	5.04	(0.03)	0.01	0.07	5.75	(6.82)	12.96	(10.30)	62.77
HUMA	3.71	(0.66)	0.00	(0.15)	0.00	0.00	8.16	(8.13)	22.74

About BioAge Labs Volatility

Volatility is a rate at which the price of BioAge Labs or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of BioAge Labs may increase or decrease. In other words, similar to BioAge's beta indicator, it measures the risk of BioAge Labs and helps estimate the fluctuations that may happen in a short period of time. So if prices of BioAge Labs fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

Please read more on our technical analysis page.

	Last Reported	Projected for Next Year
Selling And Marketing Expenses	1.7 M	2.9 M
Market Cap	123 M	109.3 M

BioAge Labs' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on BioAge Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much BioAge Labs' price varies over time.

3 ways to utilize BioAge Labs' volatility to invest better

Higher BioAge Labs' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of BioAge Labs stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. BioAge Labs stock volatility can provide helpful information for making investment decisions in the following ways:

Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of BioAge Labs investment. A higher volatility means higher risk and potentially larger changes in value.
Identifying Opportunities: High volatility in BioAge Labs' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
Diversification: Understanding how the volatility of BioAge Labs' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.

Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

BioAge Labs Investment Opportunity

BioAge Labs has a volatility of 6.44 and is 9.2 times more volatile than Dow Jones Industrial. 57 percent of all equities and portfolios are less risky than BioAge Labs. You can use BioAge Labs to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of BioAge Labs to be traded at 20.6 in 90 days.

Modest diversification

The correlation between BioAge Labs and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioAge Labs and DJI in the same portfolio, assuming nothing else is changed.

View Details

BioAge Labs Additional Risk Indicators

The analysis of BioAge Labs' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in BioAge Labs' investment and either accepting that risk or mitigating it. Along with some common measures of BioAge Labs stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

	Risk Adjusted Performance	0.1954
	Market Risk Adjusted Performance	0.9421
	Mean Deviation	4.03
	Semi Deviation	2.58
	Downside Deviation	3.63
	Coefficient Of Variation	398.66
	Standard Deviation	6.29

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

BioAge Labs Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

	Alphabet vs. BioAge Labs
	GM vs. BioAge Labs
	Visa vs. BioAge Labs
	Ford vs. BioAge Labs
	Microsoft vs. BioAge Labs
	Citigroup vs. BioAge Labs

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against BioAge Labs as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. BioAge Labs' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, BioAge Labs' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to BioAge Labs.

Complementary Tools for BioAge Stock analysis

When running BioAge Labs' price analysis, check to measure BioAge Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs is operating at the current time. Most of BioAge Labs' value examination focuses on studying past and present price action to predict the probability of BioAge Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs' price. Additionally, you may evaluate how the addition of BioAge Labs to your portfolios can decrease your overall portfolio volatility.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC